首页> 美国卫生研究院文献>Marine Drugs >Recombinant Expression of Thrombolytic Agent Reteplase in Marine Microalga Tetraselmis subcordiformis (Chlorodendrales Chlorophyta)
【2h】

Recombinant Expression of Thrombolytic Agent Reteplase in Marine Microalga Tetraselmis subcordiformis (Chlorodendrales Chlorophyta)

机译:溶栓剂重试酶的重组表达在海洋微藻曲线鳞片细胞(氯)叶绿素)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tetraselmis subcordiformis, a unicellular marine green alga, is used widely in aquaculture as an initial feeding for fish, bivalve mollusks, penaeid shrimp larvae, and rotifers because of its rich content of amino acids and fatty acids. A stable nuclear transformation system using the herbicide phosphinothricin (PPT) as a selective reagent was established previously. In this research, the recombinant expression in T. subcordiformis was investigated by particle bombardment with the rt-PA gene that encodes the recombinant human tissue-type plasminogen activator (Reteplase), which is a thrombolytic agent for acute myocardial infarction treatment. Transgenic algal strains were selected by their resistance to PPT, and expression of rt-PA was validated by PCR, Southern blotting, and Western blotting, and bioactivity of rt-PA was confirmed by the fibrin agarose plate assay for bioactivity. The results showed that rt-PA was integrated into the genome of T. subcordiformis, and the expression product was bioactive, indicating proper post-transcriptional modification of rt-PA in T. subcordiformis. This report contributes to efforts that take advantage of marine microalgae as cell factories to prepare recombinant drugs and in establishing a characteristic pathway of oral administration in aquaculture.
机译:一种单细胞海洋绿藻,一种单细胞海洋藻类,广泛用于水产养殖中,作为鱼,双恶物软体动物,Penaeid虾幼虫和转子,因为其富含氨基酸和脂肪酸的初始喂养。使用除草剂膦酸(PPT)作为选择性试剂的稳定核转化系统是在先前建立的。在该研究中,通过用RT-PA基因对T. subcordifordis的重组表达进行编码重组人组织型纤溶酶原激活剂(保留酶),其是急性心肌梗死治疗的溶栓剂。通过它们对PPT的抗性选择转基因藻类菌株,并通过PCR,Southern印迹和Western印迹验证了RT-PA的表达,并且通过纤维蛋白琼脂糖板测定来证实RT-PA的生物活性进行生物活性。结果表明,RT-PA被整合到T.Subcordifordis的基因组中,表达产物是生物活性的,表明在T.Subcordiformis中的RT-Pa的适当转录后修饰。本报告有助于利用海洋​​微藻作为细胞工厂的努力,以制备重组药物,并在水产养殖中建立口服施用的特征途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号